{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:20:10Z","timestamp":1764174010390},"reference-count":40,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["lrjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.leukres.2013.07.013","type":"journal-article","created":{"date-parts":[[2013,8,23]],"date-time":"2013-08-23T03:30:34Z","timestamp":1377228634000},"page":"1532-1537","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Wnt5a enhances the response of CML cells to Imatinib Mesylate through JNK activation and \u03b3-catenin inhibition"],"prefix":"10.1016","volume":"37","author":[{"given":"Chang-Chun","family":"Niu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ru","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ke","family":"Si","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2013.07.013_bib0005","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/107327480901600202","article-title":"Signaling networks associated with BCR-ABL-dependent transformation","volume":"16","author":"Hazlehurst","year":"2009","journal-title":"Cancer Control"},{"key":"10.1016\/j.leukres.2013.07.013_bib0010","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood-2008-03-144790","article-title":"Molecular biology of bcr-abl1-positive chronic myeloid leukemia","volume":"113","author":"Quintas-Cardama","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.07.013_bib0015","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"Deininger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.07.013_bib0020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ccr.2010.04.025","article-title":"Wnt\/Ca2+\/NFAT signaling maintains survival of Ph+ leukemia cells upon inhibition of Bcr-Abl","volume":"18","author":"Gregory","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2013.07.013_bib0025","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/sj.emboj.7601485","article-title":"Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation","volume":"26","author":"Coluccia","year":"2007","journal-title":"EMBO J"},{"key":"10.1016\/j.leukres.2013.07.013_bib0030","doi-asserted-by":"crossref","first-page":"8224","DOI":"10.1158\/0008-5472.CAN-05-0303","article-title":"Disruption of the inhibitor of apoptosis protein survivin sensitizes Bcr-abl-positive cells to STI571-induced apoptosis","volume":"65","author":"Wang","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2013.07.013_bib0035","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ccr.2007.11.003","article-title":"Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo","volume":"12","author":"Zhao","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2013.07.013_bib0040","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/leu.2008.262","article-title":"beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia","volume":"23","author":"Hu","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2013.07.013_bib0045","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.stem.2012.02.017","article-title":"Genetic and pharmacologic inhibition of beta-catenin targets imatinib-resistant leukemia stem cells in CML","volume":"10","author":"Heidel","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.leukres.2013.07.013_bib0050","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1182\/blood-2004-12-4704","article-title":"Regulation of survivin expression through Bcr-Abl\/MAPK cascade: targeting survivin overcomes imatinib resistance and increases imatinib sensitivity in imatinib-responsive CML cells","volume":"107","author":"Carter","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.07.013_bib0055","first-page":"8664","article-title":"Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer","volume":"61","author":"Zhang","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2013.07.013_bib0060","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.bjc.6605174","article-title":"The opposing roles of Wnt-5a in cancer","volume":"101","author":"McDonald","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.leukres.2013.07.013_bib0065","doi-asserted-by":"crossref","first-page":"27973","DOI":"10.1074\/jbc.M802325200","article-title":"Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating c-Jun N-terminal kinase via actin-binding protein filamin A","volume":"283","author":"Nomachi","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2013.07.013_bib0070","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1046\/j.1365-2443.2003.00662.x","article-title":"The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a\/JNK signalling pathway","volume":"8","author":"Oishi","year":"2003","journal-title":"Genes Cells"},{"key":"10.1016\/j.leukres.2013.07.013_bib0075","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1182\/blood-2010-07-299644","article-title":"c-JUN promotes BCR-ABL-induced lymphoid leukemia by inhibiting methylation of the 5\u2032 region of Cdk6","volume":"117","author":"Kollmann","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.07.013_bib0080","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ng946","article-title":"Survival signaling mediated by c-Jun NH(2)-terminal kinase in transformed B lymphoblasts","volume":"32","author":"Hess","year":"2002","journal-title":"Nat Genet"},{"issue":"Suppl. 1","key":"10.1016\/j.leukres.2013.07.013_bib0085","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/10428194.2010.546919","article-title":"Regulation of mammalian target of rapamycin and mitogen activated protein kinase pathways by BCR-ABL","volume":"52","author":"Redig","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2013.07.013_bib0090","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1600-0854.2009.00897.x","article-title":"14-3-3 ligand prevents nuclear import of c-ABL protein in chronic myeloid leukemia","volume":"10","author":"Mancini","year":"2009","journal-title":"Traffic"},{"key":"10.1016\/j.leukres.2013.07.013_bib0095","first-page":"188","article-title":"Pharmacologic mitogen-activated protein\/extracellular signal-regulated kinase kinase\/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr\/Abl-expressing human leukemia cells","volume":"62","author":"Yu","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2013.07.013_bib0100","first-page":"2976","article-title":"Flavopiridol potentiates STI571-induced mitochondrial damage and apoptosis in BCR-ABL-positive human leukemia cells","volume":"8","author":"Yu","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2013.07.013_bib0105","first-page":"2118","article-title":"Histone deacetylase inhibitors promote STI571-mediated apoptosis in STI571-sensitive and -resistant Bcr\/Abl+ human myeloid leukemia cells","volume":"63","author":"Yu","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2013.07.013_bib0110","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3892\/ijmm.2012.1207","article-title":"Downregulation of gamma-catenin inhibits CML cell growth and potentiates the response of CML cells to imatinib through beta-catenin inhibition","volume":"31","author":"Niu","year":"2013","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.leukres.2013.07.013_bib0115","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1182\/blood-2003-04-1074","article-title":"In vitro efficacy of combined treatment depends on the underlying mechanism of resistance in imatinib-resistant Bcr-Abl-positive cell lines","volume":"103","author":"La Rosee","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.07.013_bib0120","first-page":"367","article-title":"WNT5A expression is regulated by the status of its promoter methylation in leukaemia and can inhibit leukemic cell malignant proliferation","volume":"25","author":"Deng","year":"2011","journal-title":"Oncol Rep"},{"key":"10.1016\/j.leukres.2013.07.013_bib0125","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1182\/blood-2007-06-094870","article-title":"WNT5A is epigenetically silenced in hematologic malignancies and inhibits leukemia cell growth as a tumor suppressor","volume":"110","author":"Ying","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.07.013_bib0130","first-page":"2199","article-title":"Effects of stable Wnt5a overexpression on biological characers of K562 cells","volume":"31","author":"Chang-chun","year":"2009","journal-title":"Acta Academiae Medicinae Militaris Tertiae"},{"key":"10.1016\/j.leukres.2013.07.013_bib0135","first-page":"63","article-title":"The Wnt5a\/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells","volume":"27","author":"Yuan","year":"2011","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.leukres.2013.07.013_bib0140","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1535-6108(03)00268-X","article-title":"Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue","volume":"4","author":"Liang","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2013.07.013_bib0145","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.2174\/092986712801661040","article-title":"Survivin as a prognostic\/predictive marker and molecular target in cancer therapy","volume":"19","author":"Rodel","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.leukres.2013.07.013_bib0150","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1111\/j.1349-7006.2008.00870.x","article-title":"Cancer cells survive with survivin","volume":"99","author":"Yamamoto","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.leukres.2013.07.013_bib0155","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.canlet.2004.10.034","article-title":"Survivin expression in chronic myeloid leukemia","volume":"225","author":"Conte","year":"2005","journal-title":"Cancer Lett"},{"key":"10.1016\/j.leukres.2013.07.013_bib0160","first-page":"471","article-title":"Survivin and P-glycoprotein are associated and highly expressed in late phase chronic myeloid leukemia","volume":"26","author":"Reis","year":"2011","journal-title":"Oncol Rep"},{"key":"10.1016\/j.leukres.2013.07.013_bib0165","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1093\/carcin\/bgn239","article-title":"c-Jun N-terminal kinase 1 interacts with and negatively regulates Wnt\/beta-catenin signaling through GSK3beta pathway","volume":"29","author":"Hu","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.leukres.2013.07.013_bib0170","doi-asserted-by":"crossref","first-page":"e6640","DOI":"10.1371\/journal.pone.0006640","article-title":"GSK3beta is involved in JNK2-mediated beta-catenin inhibition","volume":"4","author":"Hu","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.leukres.2013.07.013_bib0175","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1096\/fj.08-117804","article-title":"JNK phosphorylates beta-catenin and regulates adherens junctions","volume":"23","author":"Lee","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.leukres.2013.07.013_bib0180","doi-asserted-by":"crossref","first-page":"16313","DOI":"10.1073\/pnas.0602557103","article-title":"Jun NH2-terminal kinase (JNK) prevents nuclear beta-catenin accumulation and regulates axis formation in Xenopus embryos","volume":"103","author":"Liao","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2013.07.013_bib0185","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.cell.2008.01.052","article-title":"Rac1 activation controls nuclear localization of beta-catenin during canonical Wnt signaling","volume":"133","author":"Wu","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2013.07.013_bib0190","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nature03914","article-title":"Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development","volume":"437","author":"Nateri","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2013.07.013_bib0195","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1083\/jcb.123.6.1857","article-title":"Expression of Wnt-1 in PC12 cells results in modulation of plakoglobin and E-cadherin and increased cellular adhesion","volume":"123","author":"Bradley","year":"1993","journal-title":"J Cell Biol"},{"key":"10.1016\/j.leukres.2013.07.013_bib0200","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/156800911794328420","article-title":"The gamma catenin\/CBP complex maintains survivin transcription in beta-catenin deficient\/depleted cancer cells","volume":"11","author":"Kim","year":"2011","journal-title":"Curr Cancer Drug Targets"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212613002403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212613002403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T11:41:14Z","timestamp":1596368474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212613002403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0145212613002403"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2013.07.013","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Wnt5a enhances the response of CML cells to Imatinib Mesylate through JNK activation and \u03b3-catenin inhibition","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2013.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}